PATENT CLAIM ANALYSIS

Application Number: 15741609
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "256000"]

Abstract:
This invention provides compounds that are inhibitors of HDAC2. The compounds (e.g., compounds according to Formula (I) or any one of Compounds 100-175) accordingly are useful for treating, alleviating, or preventing a condition in a subject such as a neurological disorder, memory or cognitive function disorder or impairment, extinction learning disorder, fungal disease or infection, inflammatory disease, hematological disease, or neoplastic disease, or for improving memory or treating, alleviating, or preventing memory loss or impairment.

Claim (Index 6):
The compound of  claim 5 , wherein R 2  is selected from para-substituted phenyl, pyridinyl, furanyl, 1H-pyrazolyl, thiazolyl, isoxazolyl, oxazolyl, isothiazolyl, 5,6-dihydro-4H-pyrrolo[1,2-b]pyrazolyl, pyridazinyl, and pyrimidinyl, and wherein R 2  is optionally additionally substituted.

Metadata:
- Claim Count in Document: 10.0
- Percentile: 86.0
- Lexical Diversity: 1.78846
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15321410', '16063682', '15067605', '15559375', '15769414']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7712401599574108
- 35 USC 102 Novelty (BERT): 0.5295260363901882
- Combined Prediction Score: 0.7470687476006885
- Mean Citation Score: 308.301164
- Max Citation Score: 331.46362
- Similarity Product: 259.074592536813

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test